rs1085307088
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PVS1_ModeratePM2PP5
The NM_005732.4(RAD50):c.3806_3807delAT(p.His1269ArgfsTer2) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,820 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005732.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAD50 | NM_005732.4 | c.3806_3807delAT | p.His1269ArgfsTer2 | frameshift_variant | Exon 25 of 25 | ENST00000378823.8 | NP_005723.2 | |
TH2LCRR | NR_132125.1 | n.155_156delAT | non_coding_transcript_exon_variant | Exon 2 of 3 | ||||
TH2LCRR | NR_132126.1 | n.175-3967_175-3966delAT | intron_variant | Intron 1 of 1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAD50 | ENST00000378823.8 | c.3806_3807delAT | p.His1269ArgfsTer2 | frameshift_variant | Exon 25 of 25 | 1 | NM_005732.4 | ENSP00000368100.4 | ||
ENSG00000283782 | ENST00000640655.2 | c.3509_3510delAT | p.His1170ArgfsTer2 | frameshift_variant | Exon 26 of 26 | 5 | ENSP00000491596.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251296Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135804
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461820Hom.: 0 AF XY: 0.00000138 AC XY: 1AN XY: 727218
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1Uncertain:1
The c.3806_3807delAT variant, located in coding exon 25 of the RAD50 gene, results from a deletion of two nucleotides at nucleotide positions 3806 to 3807, causing a translational frameshift with a predicted alternate stop codon (p.H1269Rfs*2). Frameshifts are typically deleterious in nature, however, this frameshift occurs at the 3' terminus of RAD50, is not expected to trigger nonsense-mediated mRNA decay, and impacts only the last 44 amino acids of the protein. The exact functional impact of these altered amino acids is unknown at this time. This alteration has been previously reported in a Chinese ovarian cancer patient who underwent multi-gene panel testing (Zhao Q et al. J Gynecol Oncol. 2017 Jan;28:e39). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
This sequence change creates a premature translational stop signal (p.His1269Argfs*2) in the RAD50 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 44 amino acid(s) of the RAD50 protein. This variant is present in population databases (no rsID available, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with breast or ovarian cancer (PMID: 28541631, 29726012). ClinVar contains an entry for this variant (Variation ID: 225451). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts the ATPase-C domain, which is important for RAD50 ATPase activity (PMID: 10892749, 24894818). While functional studies have not been performed to directly test the effect of this variant on RAD50 protein function, this suggests that disruption of this region of the protein is causative of disease. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Nijmegen breakage syndrome-like disorder Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at